SENATE, No. 941

STATE OF NEW JERSEY

214th LEGISLATURE

 

INTRODUCED FEBRUARY 4, 2010

 


 

Sponsored by:

Senator  CHRISTOPHER "KIP" BATEMAN

District 16 (Morris and Somerset)

Senator  ROBERT W. SINGER

District 30 (Burlington, Mercer, Monmouth and Ocean)

 

 

 

 

SYNOPSIS

     Clarifies informed consent provisions of “Access to Medical Research Act” for persons with developmental disabilities.

 

CURRENT VERSION OF TEXT

     As introduced.

  


An Act concerning informed consent for medical research and amending P.L.1977, c. 82.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    Section 5 of P.L. 1977, c. 82 (30:6D-5) is amended to read as follows:

     a.     No person receiving services for the developmentally disabled at any facility shall:

     (1)   be subjected to any corporal punishment;

     (2)   be administered any medication or chemical restraint, except upon the written authorization of a physician when necessary and appropriate as an element of the service being received or as a treatment of any medical or physical condition in conformity with accepted standards for such treatment. The nature, amount of, and reasons for the administration of any medication or chemical restraint shall be promptly recorded in such person's medical record;

     (3)   be physically or chemically restrained or isolated in any manner, except  in emergency situations for the control of violent, disturbed or depressed  behavior which may immediately result in or has resulted in harm to such person  or other person or in substantial property damage.

     The chief administrator of the facility, or his designee, shall be notified  immediately upon the application of any such restraint or isolation, and thereafter such restraint or isolation shall be continued only upon the written order of the administrator or designee.  Such order shall be effective for not more than 24 hours, and may be renewed for additional periods of not more than  24 hours each if the administrator or designee shall determine that such  continued restraint or isolation is necessary.  While in restraint or  isolation, such person shall be checked by an attendant every 15 minutes, and  bathed every 24 hours.  Such restraint or isolation shall be terminated at any  time if an attending physician shall find such restraint or isolation to be medically contraindicated.  The nature, duration of, reasons for and notation of attendant checks shall be promptly recorded in such person's medical record;

     (4)   be subjected to shock treatment, psychosurgery, sterilization or medical behavioral or pharmacological research without the express and informed consent of such person, if a competent adult, or of such person's guardian ad litem specifically appointed by a court for the matter of consent to these proceedings, if a minor or an incompetent adult or a person administratively determined to be mentally deficient.  Such consent shall be made in writing and shall
be placed in such person's record.

     Either the party alleging the necessity of such procedure or such person or such person's guardian ad litem may petition a court of competent jurisdiction to hold a hearing to determine the necessity of such procedure at which the client is physically present, represented by counsel, and provided the right and opportunity to be confronted with and to cross-examine all witnesses alleging the necessity of such procedure.  In such proceedings, the burden of  proof shall be on the party alleging the necessity of such procedure.  In the event that a person cannot afford counsel, the court shall appoint an attorney  not less than 10 days before the hearing.  An attorney so appointed shall be  entitled to a reasonable fee to be determined by the court and paid by the county from which the person was admitted.  Under no circumstances may a person  in treatment be subjected to hazardous or intrusive experimental research which is not directly related to the specific goals of his treatment program.

     (5)   Notwithstanding paragraph (4) of this subsection to the contrary, nothing in this act shall prohibit consent obtained or research conducted pursuant to the provisions of P.L. 2007, c.316 (C.26:14-1 et seq.).

     b.    Every developmentally disabled person in residence at any facility shall be provided with a nutritionally adequate and sufficient diet and shall receive appropriate and sufficient medical and dental care on a regular basis and whenever otherwise necessary.

     c.     Every developmentally disabled person between the ages of 5 and 21, inclusive, in residence or full-time attendance at any facility shall be provided a thorough and efficient education suited to such person's age and abilities.

(cf: P.L.1977, c. 82, s. 5)

 

     2.    This act shall take effect immediately.

 

 

STATEMENT

 

     This bill amends section 5 of P.L.1977, c. 82 (C.30:6D-5), which contains, among other measures that protect persons with developmental disabilities, informed consent provisions in connection with an individual’s participation in medical research.  This law requires informed consent for medical behavioral and pharmacological research, and requires a court-appointed guardian ad litem to represent a person who is a minor, incompetent adult, or person administratively determined to be mentally deficient.  The law prohibits certain research that is not directly related to the specific goals of the individual’s treatment program.

     The amendment in this bill is intended to eliminate confusion and potential statutory conflict with the “Access to Medical Research Act,” P.L. 2007, c.316 (C.26:14-1 et seq.), which permits a broader range of research, provided that an institutional review board approves and oversees the research, and which authorizes certain individuals other than a guardian ad litem to provide surrogate consent for medical research when specific protective criteria are met.  Those individuals, in descending order of priority, are:

·        a guardian with authority to make health care decisions;

·        the person’s health care representative under an advance directive for health care;

·        the spouse or civil union partner, as applicable;

·        the person’s domestic partner;

·        the person’s adult son or daughter;

·        a custodial parent;

·        an adult brother or sister;

·        an adult grandchild; and

·        an available adult relative with the closest degree of kinship to the person.

     This bill would take effect immediately.